The effect of minimal dietary changes with raisins in NAFLD patients with non-significant fibrosis: A randomized controlled intervention

Food and Function

Volumn 7, Issue 11, 2016, Pages 4533-4544

  Kaliora, Andriana C ^a   Kokkinos, Alexander ^b   Diolintzi, Anastacia ^a   Stoupaki, Maria ^b   Gioxari, Aristea ^a   Kanellos, Panagiotis T ^a   Dedoussis, George V Z ^a   Vlachogiannakos, Jiannis ^b   Revenas, Constantinos ^c   Ladas, Spiros D ^b   Karathanos, Vaios T ^a,d  

^a HAROKOPIO UNIVERSITY   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c LAIKO GENERAL HOSPITAL   (Greece)

^d Agricultural Cooperatives' Union of Aeghion   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACIDS; GLUCOSE; NUTRITION; SATURATED FATTY ACIDS;

CALORIC CONTENT; DIETARY TREATMENTS; NUTRITIONAL COUNSELING; OXIDATIVE STRESS MARKERS; POST INTERVENTIONS; POTENTIAL EFFECTS; RANDOMIZED CONTROLLED CLINICAL TRIALS; ULTRASOUND SCANNING;

PATIENT TREATMENT;

BIOLOGICAL MARKER;

ADULT; BLOOD; CONTROLLED STUDY; DIET; DIET THERAPY; FEMALE; HUMAN; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; VITIS;

ADULT; BIOMARKERS; DIET; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; VITIS;

EID: 84994802341     PISSN: 20426496     EISSN: 2042650X     Source Type: Journal    
DOI: 10.1039/c6fo01040g     Document Type: Article

References (59)

1. M. Masarone A. Federico L. Abenavoli C. Loguercio M. Persico Non alcoholic fatty liver: epidemiology and natural history Rev. Recent Clin. Trials 2014 9 126 133
2. N. M. de Alwis C. P. Day Non-alcoholic fatty liver disease, the mist gradually clears J. Hepatol. 2008 48 S104 S112
3. M. Raman J. Allard Nonalcoholic fatty liver disease: A clinical approach and review Can. J. Gastroenterol. 2006 20 345 349
4. G. Vernon A. Baranova Z. M. Younossi Systematic review, the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults Aliment. Pharmacol. Ther. 2011 34 274 285
5. M. Lazo J. M. Clark The epidemiology of nonalcoholic fatty liver disease, a global perspective Semin. Liver Dis. 2008 28 339 350
6. Q. M. Anstee C. P. Day The genetics of NAFLD Nat. Rev. Gastroenterol. Hepatol. 2013 10 645 655
7. A. Wree L. Broderick A. Canbay H. M. Hoffman A. E. Feldstein From NAFLD to NASH to cirrhosis-new insights into disease mechanisms Nat. Rev. Gastroenterol. Hepatol. 2013 10 627 636
8. S. Coulon F. Heindryckx A. Geerts C. Van Steenkiste I. Colle H. Van Vlierberghe Angiogenesis in chronic liver disease and its complications Liver Int. 2011 31 146 162
9. R. Pais F. Charlotte L. Fedchuk P. Bedossa P. Lebray T. Poynard et al., LIDO Study Group. A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver J. Hepatol. 2013 59 550 556
10. N. Kobyliak L. Abenavoli T. Falalyeyeva O. Virchenko B. Natalia T. Beregova P. Bodnar M. Spivak Prevention of NAFLD development in rats with obesity via the improvement of pro/antioxidant state by cerium dioxide nanoparticles Clujul. Med. 2016 89 229 335
11. V. G. Giby T. A. Ajith Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver disease World J. Hepatol. 2014 570 579
12. C. Finelli G. Tarantino Is there any consensus as to what diet or lifestyle approach is the right one for NAFLD patients? J. Gastrointestin Liver Dis. 2012 21 293 302
13. D. E. Larson-Meyer B. R. Newcomer L. K. Heilbronn J. Volaufova S. R. Smith A. J. Alfonso et al., The Pennington CALERIE Team. Effect of a 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function Obesity (Silver Spring) 2008 16 1355 1362
14. K. Sevastianova A. Santos A. Kotronen A. Hakkarainen J. Makkonen K. Silander et al., Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans Am. J. Clin. Nutr. 2012 96 727 734
15. K. Shah A. Stufflebam T. N. Hilton D. R. Sinacore S. Klein D. T. Villareal Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults Obesity (Silver Spring) 2009 17 2162 2168
16. R. Jin J. A. Welsh N. A. Le J. Holzberg P. Sharma D. R. Martin et al., Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD Nutrients 2014 6 3187 3201
17. J. D. Browning J. A. Baker T. Rogers J. Davis S. Satapati S. C. Burgess Short-term weight loss and hepatic triglyceride reduction, evidence of a metabolic advantage with dietary carbohydrate restriction Am. J. Clin. Nutr. 2011 93 1048 1052
18. C. Fierbinteanu-Braticevici L. Negreanu G. Tarantino Is fatty liver always benign and should not consequently be treated? J. Physiol. Pharmacol. 2013 64 3 9
19. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease European Association for the Study of the Liver (EASL). Electronic address: easloffice@easloffice.eu; European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO) J. Hepatol. 2016 64 1388 1402
20. C. Thoma C. P. Day M. I. Trenell Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review J Hepatol. 2012 56 255 266
21. M. C. Ryan C. Itsiopoulos T. Thodis G. Ward N. Trost S. Hofferberth K. O'Dea P. V. Desmond N. A. Johnson A. M. Wilson The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease J. Hepatol. 2013 59 138 143
22. F. S. Zhu S. Liu X. M. Chen Z. G. Huang D. W. Zhang Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia World J. Gastroenterol. 2008 14 6395 6400
23. T. Eslamparast H. Poustchi F. Zamani M. Sharafkhah R. Malekzadeh A. Hekmatdoost Synbiotic supplementation in nonalcoholic fatty liver disease, a randomized, double-blind, placebo-controlled pilot study Am. J. Clin. Nutr. 2014 99 535 542
24. M. H. Pan C. S. Lai M. L. Tsai C. T. Ho Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds Mol. Nutr. Food Res. 2014 58 147 171
25. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Enducation Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) J. Am. Med. Assoc. 2001 285 2486 2497
26. M. Kugelmans D. B. Hill B. Vivian L. Marsano C. J. McClain Cytokines and NASH, a pilot study of the effects of lifestyle modification and vitamin E Hepatology 2003 38 413 419
27. C. L. Wang L. Liang J. F. Fu C. C. Zou F. Hong J. Z. Xue et al., Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children World J. Gastroenterol. 2008 14 1598 1602
28. A. Chiou V. T. Karathanos A. Mylona F. N. Salta F. Preventi N. K. Andrikopoulos Currants (Vitis vinifera L.) content of simple phenolics and antioxidant activity Food Chem. 2007 102 516 522
29. W. T. Friedewald R. I. Levy D. S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin. Chem. 1972 18 499 502
30. P. Angulo J. M. Hui G. Marchesini E. Bugianesi J. George G. C. Farrell et al., The NAFLD Fibrosis Score, a noninvasive system that identifies liver fibrosis in patients with NAFLD Hepatology 2007 45 846 854
31. D. B. Panagiotakos C. Pitsavos F. Arvaniti C. Stefanadis Adherence to the Mediterranean food pattern predicts the prevalence of hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults, the accuracy of the MedDietScore Prev. Med. 2007 44 335 340
32. H. Esterbauer G. Jurgens Mechanistic and genetic aspects of susceptibility of LDL to oxidation Curr. Opin. Lipidol. 1993 4 114 124
33. Y. Tamura Y. Tanaka F. Sato J. B. Choi H. Wataba N. Masataka et al., Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patients J. Clin. Endocrinol. Metab. 2005 90 3191 3196
34. M. A. Huang J. K. Greenson C. Chao L. Anderson D. Peterman J. Jacobson et al., One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis, a pilot study Am. J. Gastroenterol. 2005 100 1072 1081
35. D. E. Larson-Meyer L. K. Heilbronn L. M. Redman B. R. Newcomer M. I. Frisard S. Anton et al., Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects Diabetes Care 2006 29 1337 1344
36. E. L. Thomas A. E. Brynes G. Hamilton N. Patel A. Spong R. D. Goldin et al., Effect of nutritional counselling on hepatic, muscle and adipose tissue fat content and distribution in non-alcoholic fatty liver disease World J. Gastroenterol. 2006 12 5813 5819
37. R. Aller D. A. De Luis O. Izaola B. De La Fuente R. Bachiller Effect of a high monounsaturated vs. high polyunsaturated fat hypocaloric diets in nonalcoholic fatty liver disease Eur. Rev. Med. Pharmacol. Sci. 2014 18 1041 1047
38. F. Sato Y. Tamura H. Watada N. Kumashiro Y. Igarashi H. Uchino et al., Effects of diet-induced moderate weight reduction on intrahepatic and intramyocellular triglycerides and glucose metabolism in obese subjects J. Clin. Endocrinol. Metab. 2007 92 3326 3329
39. K. F. Petersen S. Dufour D. Befroy M. Lehrke R. E. Hendler G. I. Shulman Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes Diabetes 2005 54 603 608
40. F. M. Trovato D. Catalano G. F. Martines P. Pace G. M. Trovato Mediterranean diet and non-alcoholic fatty liver disease, the need of extended and comprehensive interventions Clin. Nutr. 2015 34 86 88
41. D. R. Keast C. E. O'Neil J. M. Jones Dried fruit consumption is associated with improved diet quality and reduced obesity in US adults, National Health and Nutrition Examination Survey, 1999-2004 Nutr. Res. 2011 31 6 460 467
42. N. Dai Y. Zou L. Zhu H. F. Wang M. G. Dai Antioxidant properties of proanthocyanidins attenuate carbon tetrachloride (CCl4)-induced steatosis and liver injury in rats via CYP2E1 regulation J. Med. Food 2014 17 663 669
43. M. Aoun F. Michel G. Fouret F. Casas M. Jullien C. Wrutniak-Cabello et al., A polyphenol extract modifies quantity but not quality of liver fatty acid content in high-fat-high-sucrose diet-fed rats, possible implication of the sirtuin pathway Br. J. Nutr. 2010 104 1760 1770
44. M. Akaberi H. Hosseinzadeh Grapes (Vitis vinifera) as a Potential Candidate for the Therapy of the Metabolic Syndrome Phytother. Res. 2016 30 540 556
45. P. T. Kanellos A. C. Kaliora C. Liaskos N. K. Tentolouris D. Perrea V. T. Karathanos A study of glycemic response to Corinthian raisins in healthy subjects and in type 2 diabetes mellitus patients Plant Foods Hum. Nutr. 2013 68 145 148
46. E. B. Levitan N. R. Cook M. J. Stampfer P. M. Ridker K. M. Rexrode J. E. Buring et al., Dietary glycemic index, dietary glycemic load, blood lipids, and C-reactive protein Metabolism 2008 57 437 443
47. R. Jiang D. R. Jacobs E. Mayer-Davis M. Szklo D. Herrington N. S. Jenny et al., Nut and seed consumption and inflammatory markers in the multi-ethnic study of atherosclerosis Am. J. Epidemiol. 2006 163 222 231
48. D. J. A. Jenkins K. Srichaikul C. W. C. Kendall J. L. Sievenpiper S. Abdulnour A. Mirrahimi et al., The relation of low glycaemic index fruit consumption to glycaemic control and risk factors for coronary heart disease in type 2 diabetes Diabetologia 2011 54 271 279
49. P. T. Kanellos A. C. Kaliora A. Gioxari G. O. Christopoulou N. Kalogeropoulos V. T. Karathanos Absorption and bioavailability of antioxidant phytochemicals and increase of serum oxidation resistance in healthy subjects following supplementation with raisins Plant Foods Hum. Nutr. 2013 68 411 415
50. D. Del Rio A. Rodriguez-Mateos J. P. Spencer M. Tognolini G. Borges A. Crozier Dietary (poly)phenolics in human health, structures, bioavailability, and evidence of protective effects against chronic diseases Antioxid. Redox. Signaling 2013 18 1818 1892
51. J. Chao T. I. Huo H. Y. Cheng J. C. Tsai J. W. Liao M. S. Lee X. M. Qin M. T. Hsieh L. H. Pao W. H. Peng Gallic acid ameliorated impaired glucose and lipid homeostasis in high fat diet-induced NAFLD mice PLoS One 2014 9 2 e96969 10.1371/journal.pone.0096969.eCollection2014
52. C. Gabay I. Kushner Acute-phase proteins and other systemic responses to inflammation N. Engl. J. Med. 1999 340 448 454
53. A. Wieckowska B. G. Papouchado Z. Li R. Lopez N. N. Zein A. E. Feldstein Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis Am. J. Gastroenterol. 2008 103 1372 1379
54. G. Tarantino P. Conca F. Pasanisi M. Ariello M. Mastrolia A. Arena et al., Could inflammatory markers help diagnose nonalcoholic steatohepatitis? Eur. J. Gastroenterol. Hepatol. 2009 21 504 511
55. G. Ferraioli C. Filice L. Castera B. I. Choi I. Sporea S. R. Wilson et al., WFUMB guidelines and recommendations for clinical use of ultrasound elastography, Part 3, liver Ultrasound Med. Biol. 2015 41 1161 1179
56. G. Tarantino S. Savastano D. Capone A. Colao Spleen, A new role for an old player? World J. Gastroenterol. 2011 17 3776 3784
57. L. Wu V. V. Parekh J. Hsiao D. Kitamura L. Van Kaer Spleen supports a pool of innate-like B cells in white adipose tissue that protects against obesity-associated insulin resistance Proc. Natl. Acad. Sci. U. S. A. 2014 111 4638 4647
58. P. T. Kanellos A. C. Kaliora N. K. Tentolouris V. Argiana D. Perrea N. Kalogeropoulos et al., A pilot, randomized controlled trial to examine the health outcomes of raisin consumption in patients with diabetes Nutrition 2014 30 358 364
59. M. Blachier H. Leleu M. Peck-Radosavljevic D. C. Valla F. Roudot-Thoraval The burden of liver disease in Europe, A review of available epidemiological data J. Hepatol. 2013 58 593 608